Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-8408 preliminary market formulation pharmacokinetic crossover study
NL-OMON40769Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ruzasvir (4 arms), sponsored by Merck & Co. Primary endpoints: AUC0-*, AUClast and 5 more. Started Aug 2014; status: active, not recruiting.
02
Drugs
ruzasvir
Beyond the preview
Go deeper on NL-OMON40769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40769.